Gynecomastia is fairly common. It is a physiologic phenomenon that occurs during puberty, when at least half of males experience enlargement of one or both breasts. Pubertal hypertrophy is characterized by a tender discoid enlargement of the breast tissue beneath the areola and usually subsides spontaneously within a year.
Gynecomastia also is common among elderly men, particularly...
Source: ADAM Encyclopedia
Gynecomastia is the development of abnormally large breasts in males. It is related to the excess growth of breast tissue, rather than excess fat... Read more »
Source: Breastcancer.org
Femara (chemical name: letrozole) is an aromatase inhibitor approved by the U.S. Food and Drug Administration (FDA) to treat: post-menopausal women... Read more »
Source: Breastcancer.org
Brand name: Femara Chemical name: Letrozole Class: Aromatase inhibitor hormonal therapy. Aromasin and Arimidex are other aromatase inhibitors. How it... Read more »
Source: Breastcancer.org
Tykerb (chemical name: lapatinib) has been approved by the U.S. Food and Drug Administration (FDA): to be given in combination with Xeloda (chemical... Read more »
Source: ADAM Encyclopedia
47 X-X-Y syndromeSymptomsAbnormal body proportions (long legs, short trunk, shoulder equal to hip size)Abnormally large breasts... Read more »